Bharucha David
Chief Medical Officer
Bharucha David has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 28, 2026.
On the most recent filing, Bharucha David is listed as Chief Medical Officer at Milestone Pharmaceuticals Inc. Inside the rolling window, Bharucha David reported no open-market purchases and 2 open-market sales totaling $158K in MIST. The largest disclosed transaction in the window is a sale of 58,007 MIST shares on Dec 15, 2025, worth $135K.
Companies traded
Other insiders at MIST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$158K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bharucha David made?
Bharucha David has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Bharucha David trade?
Bharucha David has filed SEC Form 4 disclosures for 1 company, including MIST.
When was Bharucha David's most recent SEC Form 4 filing?
Bharucha David's most recent SEC Form 4 filing on Tracefour is dated Jan 28, 2026.
What is Bharucha David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bharucha David is listed as Chief Medical Officer.
What is Bharucha David's total buy and sell value in the current window?
Inside the rolling retention window, Bharucha David bought $0 and sold $158K based on SEC Form 4 filings.
What was Bharucha David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 58,007 MIST shares on 2025-12-15, worth $135K, per SEC Form 4 filings.